Update: The results of this research are in! Find out more here. How can pharmacogenetic testing improve care for elderly patients taking multiple medications? Genelex is trying to find out.…
Read More
Those suffering from chronic pain need individualized care strategies to be best served by their physicians, according to the recent findings of an expert panel convened by the National Institutes…
Read More
With Father’s Day approaching, what better way to celebrate the men you call family and friends than by helping to make sure they take their health seriously? June is National…
Read More
A new report recognizes the frustration physicians commonly have with drug-drug interaction (DDI) alerts in clinical decision support software and presents a number of ways they could be improved. “Improving…
Read More
Could the reason why the placebo effect works for some people and not others lie in their DNA? The authors of a new scientific review article make the case that,…
Read More
After June 21, Medicare will limit coverage for the core drug-sensitivity genetic tests that comprise YouScript’s Polypharmacy test panel. This means that if you or a loved one are 65…
Read More
Recent research sponsored by Genelex and undertaken by University of Utah researchers has been recognized at the national Academy of Managed Care Pharmacy (AMCP) conference. The research shows that as many…
Read More
By Howard Coleman, Genelex CEO The week of May 9 saw scores of scientists, researchers and clinical laboratory professionals descend on the nation’s capital for the annual American Clinical Laboratory…
Read More
Researchers seeking to fill a knowledge gap in what’s known about the magnitude of pediatric drug-related ER visits have found that 1 in 12 ER trips for children involved medications.…
Read More
Physicians and family taking care of a 6-year-old boy diagnosed with attention deficit hyperactivity disorder (ADHD) found a common medication used to treat the condition was having the reverse effect.…
Read More
